Literature DB >> 16965337

No evidence of Epstein-Barr virus association with Merkel cell carcinoma.

Maren Shaw1, Simon Warren, Pamela Groben, Margaret L Gulley.   

Abstract

BACKGROUND: Merkel cell carcinoma (MCC) is an aggressive tumor of cutaneous neuroendocrine cells with a reported 13-fold increased incidence in immunocompromised patients, raising the possibility that it is driven by an oncogenic virus. Additionally, Merkel cell hyperplasia is seen in the Epstein-Barr virus (EBV)-driven process oral hairy leukoplakia, and EBV is known to be involved in the pathogenesis of several other malignancies.
OBJECTIVE: We tested the hypothesis that EBV is involved in MCC.
METHODS: We employed EBV-encoded RNA in situ hybridization (ISH), lytic EBV ISH, latent membrane protein 1 immunohistochemistry, and BamH1Z leftward reading frame 1 immunohistochemistry to detect and localize EBV in paraffin sections of MCC from five patients as well as seven other cutaneous tumors and positive controls for EBV infection.
RESULTS: Positive controls reacted appropriately. However, there was no evidence of latent or lytic EBV in any of the MCC biopsies or other cutaneous tumors.
CONCLUSION: Our findings suggest that EBV is not associated with MCC. Copyright Blackwell Munksgaard 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965337     DOI: 10.1111/j.1600-0560.2006.00498.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

Review 1.  [Merkel cell carcinoma: a highly aggressive tumor with possible viral etiology].

Authors:  F Toberer; S Werchau; M Bischof; M Büchler; A Enk; P Helmbold
Journal:  Chirurg       Date:  2011-08       Impact factor: 0.955

2.  An unusual case of Merkel cell carcinoma.

Authors:  Eva-Susanne Strobel; Petra Feyer; Maria Steingräber; Annette Schmitt-Gräff; Peter Karl Kohl
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-25       Impact factor: 4.553

3.  Lack of efficacy of radiation therapy plus PD-L1 blockade for Merkel cell carcinoma arising in a patient with chronic active Epstein-Barr virus infection.

Authors:  Ayaka Okazaki; Kozo Nakai; Nao Kusutani; Riei Kamo; Yoshie Fukunaga; Kotaro Nagase; Paul Nghiem; Daisuke Tsuruta
Journal:  Dermatol Ther       Date:  2021-01-05       Impact factor: 3.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.